Thomas Cahill

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Cahill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Director Stock Option (right to buy) 45,000 01 Aug 2025 Direct

Insider Reports Filed by Thomas Cahill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRME Prime Medicine, Inc. 01 Aug 2025 4 $0 4 Director 05 Aug 2025, 20:42
PRME Prime Medicine, Inc. 04 Jun 2025 1 $0 4 Director 05 Jun 2025, 18:11
PRME Prime Medicine, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:58
PRME Prime Medicine, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 17:51
PRME Prime Medicine, Inc. 24 Oct 2022 4 +$6,800,000 4 Director 26 Oct 2022, 20:00
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3 Director 19 Oct 2022, 20:03